Florida Selects DiaCarta’s cfDNA Test to Detect Early Response of Cancer Treatment
The Florida Health Department will use DiaCarta’s RadTox test for early detection of cancer treatment response and resistance.
Read MorePosted by Andy Lundin | Mar 11, 2024 | Cancer, Molecular Diagnostics |
The Florida Health Department will use DiaCarta’s RadTox test for early detection of cancer treatment response and resistance.
Read MorePosted by Andy Lundin | Mar 8, 2024 | Immunoassay Reagents & test Kits, Womens Health |
The test is for use with the Triage MeterPro for the quantitative determination of placental growth factor in maternal plasma specimens.
Read MorePosted by Andy Lundin | Mar 7, 2024 | Sexually Transmitted Diseases |
Thee American Medical Association launched a new toolkit to help increase screenings for HIV, STIs, viral hepatitis and latent tuberculosis.
Read MorePosted by Andy Lundin | Mar 4, 2024 | Diagnostic Technologies, Respiratory Disease |
Diasorin received FDA 510(k) clearance for its new Liaison Plex platform and first panel of tests, the Liaison Plex Respiratory Flex Assay.
Read MorePosted by Andy Lundin | Mar 1, 2024 | Prostate |
AI has helped scientists reveal a new form of aggressive prostate cancer which could revolutionize how the disease is diagnosed in the future.
Read More